FOXO1 and posterior cortical atrophy: In PCa cell models, the Nodal pathway leads to EMT changes and metastasis through FOXO1/3a activation; interestingly, treatment of PCa cells with FOXO inhibitor AS1842856 resulted in blockage of the Nodal pathway, suggesting a potential target for the control of metastatic disease in PCa cases [163].